Variant report
| Variant | nsv528625 |
|---|---|
| Chromosome Location | chr5:179618961-179625630 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:1 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr5:179622475..179625183-chr5:179637307..179639559,2 | K562 | blood: |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs11249682 | chr5:179618961-179618962 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 2 | rs528672644 | chr5:179618983-179618984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs546818316 | chr5:179619016-179619017 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs34351120 | chr5:179619049-179619050 | Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 5 | rs182688297 | chr5:179619059-179619060 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs34570575 | chr5:179619074-179619075 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs185541148 | chr5:179619084-179619085 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs146364594 | chr5:179619160-179619161 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs138554494 | chr5:179619182-179619183 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs566582146 | chr5:179619183-179619184 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs7737438 | chr5:179619222-179619223 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 12 | rs144458061 | chr5:179619232-179619233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs377626792 | chr5:179619242-179619243 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs576882427 | chr5:179619286-179619287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs576560725 | chr5:179619288-179619289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs537513319 | chr5:179619319-179619320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs555764717 | chr5:179619343-179619344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs574075712 | chr5:179619345-179619346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs6601096 | chr5:179619347-179619348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs561238143 | chr5:179619354-179619355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs191087064 | chr5:179619355-179619356 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs540822790 | chr5:179619362-179619363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs7719326 | chr5:179619400-179619401 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 24 | rs544689538 | chr5:179619406-179619407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs79019095 | chr5:179619455-179619456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs142491535 | chr5:179619554-179619555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs147220958 | chr5:179619615-179619616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs566763621 | chr5:179619626-179619627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs6880031 | chr5:179619654-179619655 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 30 | rs6880032 | chr5:179619657-179619658 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 31 | rs182451271 | chr5:179619665-179619666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs6898339 | chr5:179619672-179619673 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 33 | rs555826110 | chr5:179619679-179619680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs6859090 | chr5:179619681-179619682 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 35 | rs535077801 | chr5:179619682-179619683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs187786099 | chr5:179619692-179619693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs6880061 | chr5:179619730-179619731 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 38 | rs540533261 | chr5:179619732-179619733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs202087310 | chr5:179619750-179619751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs59956150 | chr5:179619751-179619752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs200089262 | chr5:179619752-179619753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs201735553 | chr5:179619767-179619768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs559128785 | chr5:179619772-179619773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs193136287 | chr5:179619796-179619797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs183207378 | chr5:179619806-179619807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs544751061 | chr5:179619811-179619812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs140562226 | chr5:179619820-179619821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs530172048 | chr5:179619830-179619831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs542672409 | chr5:179619869-179619870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs187530672 | chr5:179619908-179619909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Gastrointestinal stromal cancer | 16982739 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Phyllodes tumor | 17334353 | CNVD |
| Malaria | 21533027 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Cancer | 20164919 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Cancer | 16751803 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Glioma | 20126413 | CNVD |
| Cancer | 22429812 | CNVD |
| Cancer | 21637783 | CNVD |
| Colorectal cancer | 20709793 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Leukemia | 17361228 | CNVD |
| Myelodysplastic syndrome | 18508791 | CNVD |
| 5q-syndrome | 17576883 | CNVD |
| Gastric cancer | 17908304 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Barrett''s syndrome | 19417022 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| Salivary gland tumor | 18059337 | CNVD |
| Renal cell carcinoma | 19377443 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Gastrointestinal stromal cancer | 19259404 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Embryonal rhabdomyosarcoma | 16790082 | CNVD |
| Biliary cancer | 20360734 | CNVD |
| Breast cancer | 20360734 | CNVD |
| Coronary artery disease | 20360734 | CNVD |
| Crohn''s disease | 20360734 | CNVD |
| Hypertension | 20360734 | CNVD |
| Rheumatoid arthritis | 20360734 | CNVD |
| Type 1 diabetes | 20360734 | CNVD |
| Type 2 diabetes | 20360734 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| epilepsy | 18472482 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Sotos syndrome | 21572526 | CNVD |
| T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
| Sotos syndrome | 17561922 | CNVD |
| Sotos syndrome | 16773131 | CNVD |
| Mental retardation | 16773131 | CNVD |
| Sotos syndrome | 22470819 | CNVD |
| Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
| Acute myeloid leukemia | 18000384 | CNVD |
| Sudden cardiac death | 19188705 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| abnormal development | 18461090 | CNVD |
| T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
| Lung cancer | 17297452 | CNVD |
| Cancer | 20164920 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Breast cancer | 21804112 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Sotos syndrome | 22283845 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Sotos syndrome | 20503325 | CNVD |
| Lung adenocarcinoma | 17086460 | CNVD |
| Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Breast cancer | 19181860 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| Ehlers-danlos syndrome | 17576883 | CNVD |
| Lung cancer | 17086460 | CNVD |
| Autism | 19246517 | CNVD |
| Basal cell lymphoma | 19029149 | CNVD |
| Diffuse large b-cell lymphoma | 19029149 | CNVD |
| Autism | 20808228 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Autism | 22543975 | CNVD |
| Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| Breast cancer | 22522925 | CNVD |
| Melanoma | 20877625 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr5:179618200-179624400 | Weak transcription | Fetal Brain Female | brain |
| 2 | chr5:179618800-179619400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
| 3 | chr5:179619000-179619200 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 4 | chr5:179620600-179635400 | Weak transcription | Right Atrium | heart |
| 5 | chr5:179621000-179622600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
| 6 | chr5:179621600-179622400 | Enhancers | HepG2 | liver |
| 7 | chr5:179621800-179622200 | Enhancers | Spleen | Spleen |
| 8 | chr5:179621800-179622400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
| 9 | chr5:179622000-179622400 | Enhancers | Pancreas | Pancrea |
| 10 | chr5:179622400-179625000 | Weak transcription | Pancreas | Pancrea |
| 11 | chr5:179622600-179624200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
| 12 | chr5:179624200-179624400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
| 13 | chr5:179624200-179625000 | Enhancers | Fetal Brain Male | brain |
| 14 | chr5:179624400-179624800 | Enhancers | Fetal Brain Female | brain |
| 15 | chr5:179624400-179624800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
| 16 | chr5:179625000-179625200 | Active TSS | Pancreas | Pancrea |






